Search | IOVS | ARVO Journals

Showing 1 – 20 of 235

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2022

Pigment Epithelial Detachment Vascularity Index (PEDVI) in Neovascular Age-Related Macular Degeneration: An Image Processing Approach

Amrish Selvam; Manan Patel; Arnim Kuchhal; Joshua Ong; Mohammed Abdul Rasheed; Shanmukh Reddy Manne; Mohammed Nasar Ibrahim; Jose Alain Sahel; Kiran Kumar Vupparaboina; Jay Chhablani

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):1024 – F0271. doi:

ARVO Annual Meeting Abstract June 2022

Three-dimensional (3-D) analysis of the Haller's vessels in diseased eyes: comparison with healthy eyes

Jay Chhablani; Sumit Singh; Mohammed Nasar Ibrahim; Anindya Samanta; Amrish Selvam; Vinisha Sant; Mohammed Abdul Rasheed; Jose Alain Sahel; Kiran Kumar Vupparaboina

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):484 – A0021. doi:

ARVO Annual Meeting Abstract June 2022

Three-dimensional choroidal contour mapping in pathology:comparison with healthy controls

Supriya Arora; Brian Rosario; Amrish Selvam; Vinisha Sant; Mohammed Nasar Ibrahim; Jose Alain Sahel; Kiran Kumar Vupparaboina; Jay Chhablani

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):483 – A0020. doi:

ARVO Annual Meeting Abstract June 2022

Three-dimensional choroidal surface topography analysis in healthy eyes based on wide-field SS-OCT volume scans

Brian Rosario; Supriya Arora; Amrish Selvam; Vinisha Sant; Mohammed Nasar Ibrahim; Jose Alain Sahel; Kiran Kumar Vupparaboina; Jay Chhablani

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2104 – F0093. doi:

ARVO Annual Meeting Abstract June 2022

Quantification of choroidal Haller’s sublayer vasculature in 3D based on wide-field SS-OCT scans using 3D tensor voting and geometric modeling

Mohammed Nasar Ibrahim; Sumit Singh; SARFORAZ BIN BASHAR; Amrish Selvam; Anindya Samanta; Mohammed Abdul Rasheed; Vinisha Sant; Jose Alain Sahel; Soumya Jana; Jay Chhablani; Kiran Kumar Vupparaboina

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2068 – F0057. doi:

ARVO Annual Meeting Abstract June 2022

The impact of luminance and disease stage on navigation performance in age related macular degeneration (AMD) - a MACUSTAR study report

Ariel Zenouda; Alina Schenk; Amina Abdirahman; Charlotte Behning; José-Alain Sahel; Adnan Tufail; Nadia Zakaria; Nick Tyler; Saddek Mohand-Said; Michel Paques; Ulrich F O Luhmann; Hannah M P Dunbar

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2456 – F0033. doi:

ARVO Annual Meeting Abstract June 2022

ADAPTIVE OPTICS AND MULTIMODAL IMAGING FOR INFLAMMATORY VITREORETINAL INTERFACE ABNORMALITIES

Marie-Helene Errera; Emmanuelle Satcho; Valerie Snyder; Kunal K Dansingani; Iman AHMAD; Adam THOMPSON A; Nikita KEDIA; Jay Chhablani; Jose Alain Sahel; Michel Paques; Ethan A Rossi

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):387 – F0425. doi:

ARVO Annual Meeting Abstract June 2022

Deep-learning based diagnostic quality assessment of choroid layer in OCT scans

Kiran Kumar Vupparaboina; Shanmukh Reddy Manne; Surya Prakash Koidala; Kalah Ozimba; Abdul Rasheed Mohammed; SARFORAZ BIN BASHAR; Jose Alain Sahel; Soumya Jana; Jay Chhablani

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2107 – F0096. doi:

ARVO Annual Meeting Abstract June 2022

Automatic identification and quantification of retinal cysts in optical coherence tomography images using deep residual encoder-decoder architecture.

Shanmukh Reddy Manne; Amrish Selvam; Manan Patel; Arnim Kuchhal; Jose Alain Sahel; Jay Chhablani; Kiran Kumar Vupparaboina; Soumya Jana

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2082 – F0071. doi:

ARVO Annual Meeting Abstract June 2022

Three dimensional analysis of Haller vessels in healthy eyes

Anindya Samanta; Mohammed Nasar Ibrahim; Sumit Singh; Amrish Selvam; Mohammed Abdul Rasheed; Jose Alain Sahel; Kiran Kumar Vupparaboina; Jay Chhablani

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2094 – F0083. doi:

ARVO Annual Meeting Abstract June 2022

SPVN06, a novel mutation-independent AAV-based gene therapy, dramatically reduces vision loss in the rd10 mouse model of rod-cone dystrophy

Florence Lorget; Melanie Marie; Hanen Khabou; Cardillia Simon; Didier Nuno; Phillip Vanlandingham; Alain Quiambao; Rafal Farjo; Deniz Dalkara; Jose Alain Sahel; Thierry D Leveillard

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):56 – A0029. doi:

ARVO Annual Meeting Abstract June 2022

VSX2 variants are responsible for bipolar cell dysfunction with distinct lens and chorioretinal alterations.

Vasily M. SMIRNOV; Matthieu Robert; Christel Condroyer; Aline Antonio; Jean-Michel Rozet; Jose Alain Sahel; Isabelle Perrault; Isabelle S Audo; Christina Zeitz

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):487 – A0064. doi:

ARVO Annual Meeting Abstract June 2022

Worldwide multicenter ocular imaging study (EyeConic) to identify patients eligible for cone-based optogenetics therapy

Lucas Janeschitz-Kriegl; Giacomo Calzetti; Michel Michaelides; Jose Alain Sahel; Zoltán Nagy; Katarina Stingl; Jin Zi-Bing; Jacque L Duncan; Eyal Banin; Byron L Lam; Michalis Georgiou; Boris Rosin; Viktória Szabo; Potyra Rosa; Bence György; Hendrik P Scholl

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):455. doi:

ARVO Annual Meeting Abstract June 2022

The phase III REFLECT trial: efficacy of bilateral gene therapy for Leber hereditary optic neuropathy (LHON) is maintained 2 years post administration

Patrick Yu-Wai-Man; Nancy Newman; Prem S Subramanian; Mark Moster; An-Guor Wang; Sean Donahue; Bart Leroy; Valerio Carelli; Valerie Biousse; Catherine Vignal-Clermont; Alfredo A Sadun; Gema Fernandez; Elizabeth Fortin; Rudrani Banik; Magali Taiel; Jose Alain Sahel

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):434. doi:

ARVO Annual Meeting Abstract June 2022

Genotype-phenotype correlation and disease modeling in RPGR -related cone and cone-rod dystrophies.

Marco Nassisi; Giuseppe De Bartolo; Saddek Mohand-Said; Christel Condroyer; Aline Antonio; Marie-Elise Lancelot; Kinga Maria Bujakowska; Vasily M. SMIRNOV; Thomas Pugliese; John Neidhardt; Jose Alain Sahel; Christina Zeitz; Isabelle S Audo

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):138 – A0318. doi:

ARVO Annual Meeting Abstract June 2022

Human corneal stromal stem cells express microRNA-29a in exosomes – a robust cell selection for stem cell therapy of corneal scarring

Gary Hin-Fai Yam; Mithun Santra; Jose Alain Sahel; James L Funderburgh; Vishal Jhanji

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):111 – A0209. doi:

ARVO Annual Meeting Abstract June 2022

Development and validation of a mobility test for Inherited Retinal Disease in real and virtual conditions - preliminary results.

Colas Nils Authié; Mylène Poujade; Alireza Talebi; Alexis Defer; Ariel Zenouda; Cecilia Coen; Yihan Zhang; Jose Alain Sahel; Saddek Mohand-Said; Philippe Chaumet-Riffaud; Isabelle S Audo

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):715 – F0443. doi:

ARVO Annual Meeting Abstract June 2022

Optogenetics in the clinic: safety and efficacy updates on the phase 1/2 clinical trial PIONEER

Jose Alain Sahel; Isabelle S Audo; Elise Boulanger-Scemama; Chloé Pagot; Angelo Arleo; Joseph N Martel; Simona Degli Esposti; Alexandre Delaux; Jean-Baptiste de Saint Aubert; Caroline de Montleau; Emmanuel Gutman; Jens Duebel; Serge Picaud; Deniz Dalkara; Magali Taiel; Botond Roska

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):1106. doi:

ARVO Annual Meeting Abstract June 2022

Potent retinal protection by oral administration of a purine metabolite against age-related retinal degeneration and RHO-associated retinitis pigmentosa

Owen Clinger; Yibo Xi; Abhishek Vats; Amanda Wolf-Johnson; Lori Birder; Edwin Jackson; Jose Alain Sahel; Yuanyuan Chen

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):1777 – F0326. doi:

ARVO Annual Meeting Abstract June 2022

Visual field loss and fitness to drive: preliminary results

julien Adrian; Caroline de Montleau; Jose Alain Sahel; Gérard Saillant; Philippe Chaumet-Riffaud

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2467 – F0044. doi:

1 2 3 4 5

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Filters

Specify Date Range

Pigment Epithelial Detachment Vascularity Index (PEDVI) in Neovascular Age-Related Macular Degeneration: An Image Processing Approach

Three-dimensional (3-D) analysis of the Haller's vessels in diseased eyes: comparison with healthy eyes

Three-dimensional choroidal contour mapping in pathology:comparison with healthy controls

Three-dimensional choroidal surface topography analysis in healthy eyes based on wide-field SS-OCT volume scans

Quantification of choroidal Haller’s sublayer vasculature in 3D based on wide-field SS-OCT scans using 3D tensor voting and geometric modeling

The impact of luminance and disease stage on navigation performance in age related macular degeneration (AMD) - a MACUSTAR study report

ADAPTIVE OPTICS AND MULTIMODAL IMAGING FOR INFLAMMATORY VITREORETINAL INTERFACE ABNORMALITIES

Deep-learning based diagnostic quality assessment of choroid layer in OCT scans

Automatic identification and quantification of retinal cysts in optical coherence tomography images using deep residual encoder-decoder architecture.

Three dimensional analysis of Haller vessels in healthy eyes

SPVN06, a novel mutation-independent AAV-based gene therapy, dramatically reduces vision loss in the rd10 mouse model of rod-cone dystrophy

VSX2 variants are responsible for bipolar cell dysfunction with distinct lens and chorioretinal alterations.

Worldwide multicenter ocular imaging study (EyeConic) to identify patients eligible for cone-based optogenetics therapy

The phase III REFLECT trial: efficacy of bilateral gene therapy for Leber hereditary optic neuropathy (LHON) is maintained 2 years post administration

Genotype-phenotype correlation and disease modeling in RPGR -related cone and cone-rod dystrophies.

Human corneal stromal stem cells express microRNA-29a in exosomes – a robust cell selection for stem cell therapy of corneal scarring

Development and validation of a mobility test for Inherited Retinal Disease in real and virtual conditions - preliminary results.

Optogenetics in the clinic: safety and efficacy updates on the phase 1/2 clinical trial PIONEER

Potent retinal protection by oral administration of a purine metabolite against age-related retinal degeneration and RHO-associated retinitis pigmentosa

Visual field loss and fitness to drive: preliminary results

To View More...

You must be signed into an individual account to use this feature.